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Background: Declining serum levels of 25-hydroxyvitamin D [25(OH)D, a biomarker
of vitamin D status] with aging is a well-recognized phenomenon. However, scarce
information is available on the relation between 25(OH)D levels and cognitive
performance over time in older individuals. Our purpose was to evaluate, longitudinally,
the association of 25(OH)D with cognitive function in a healthy older adults’ cohort.
Methods: Sixty-four individuals over 55 years-old with no cognitive impairment, clustered
as healthy “Poor” and “Good” cognitive performers, were followed for an average of
18 months. Seasonal-adjusted 25(OH)D serum levels (measured by high-performance
liquid chromatography-tandem mass spectrometry) were related, longitudinally, with
cognitive (memory and general/executive) composite scores.
Results: Overall seasonal-adjusted median serum 25(OH)D level was of 47 nmol/l
[interquartile range (IQR), 38–60 nmol/l]. A negative correlation between baseline
25(OH)D and the general/executive composite score was found in the “Poor” cognitive
performers (rs = −0.52, p = 0.006), an association lost after adjusting 25(OH)D levels for
the season. No effect was found in both groups between seasonal-adjusted 25(OH)D
levels and the variation of both memory and general/executive composites during
follow-up when adjusted for age, gender and education level.
Conclusion: In this healthy older population with no cognitive impairment, lower serum
levels of 25(OH)D were not longitudinally associated with poorer cognitive scores.
Keywords: 25-hydroxyvitamin D, vitamin D, aging, healthy aging, cognitive performance, longitudinal analysis
INTRODUCTION
Vitamin D is a steroid prohormone obtained from the diet or produced by the action of
ultraviolet light in the skin (Bouillon, 2016). Once in circulation, it is rapidly hydroxylated
in the liver into 25-OH vitamin D [25(OH)D]. Levels of 25(OH)D are considered surrogate
indicators of vitamin D homeostasis (Bouillon, 2016). While its best well-known function resides
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on the regulation of calcium homeostasis, evidence is
accumulating on the association of vitamin D deficiency
with reduced musculoskeletal health and increased risk for acute
and chronic diseases, as well as all-cause mortality (Pludowski
et al., 2013; Schöttker et al., 2014). More so, some studies found
significant positive associations between blood 25(OH)D and
several cognitive performance scores in different gender and
age groups (Annweiler et al., 2010; van der Schaft et al., 2013;
Anastasiou et al., 2014; Granic et al., 2015). However, available
observational data in older populations, evaluating various
cognition domains and 25(OH)D levels provided contradictory
results. Several, but not all, cross-sectional and prospective
studies involving adults older than 60 years have shown an
increased risk of cognitive impairment for those with low levels
of 25(OH)D (Annweiler et al., 2013; Goodwill et al., 2018). Still,
overall, very few studies have addressed this issue longitudinally
in a community-dwelling senior population setting and with
a standardized 25(OH)D serum measurement method (Perna
et al., 2014; Kuźma et al., 2016).
Here the objective was to evaluate the association between
cognitive longitudinal performance (average follow-up of
18 months) and 25(OH)D serum levels determined by
high-performance liquid chromatography-tandem mass
spectrometry. The population sample was comprised of
healthy individuals aged 55 years and older, with no cognitive




The study was conducted between March 2012 and March
2015. Summarily, the recruitment was performed in two-phases.
First, a larger sample, representative of the general Portuguese
older population in terms of age, gender, and education
underwent a full neuropsychological assessment (subjects were
randomly selected from the Guimarães and Vizela local area
health authority registries), resulting in 1,051 participants after
inclusion/exclusion criteria (Costa et al., 2013; Santos et al.,
2013, 2014). Then, of these, 120 subjects (matched for gender
and age) were chosen in order to provide cognitive profiles
of overall ‘‘good’’ cognitive performance (n = 60) and overall
‘‘poor’’ performance (n = 60) group, based on their, within
normal range, neuropsychological testing. Primary exclusion
criteria included inability to understand informed consent,
participant choice to withdraw from the study, dementia and/or
diagnosed neuropsychiatric and/or neurodegenerative disorder.
Adjusted thresholds for cognitive impairment were calculated
depending on factors such as age and/or education (Grigoletto
et al., 1999; Busch and Chapin, 2008). Thus, the Mini-Mental
State Examination (MMSE) test score thresholds applied were
the following: MMSE score <17, if individual with 4 or less
years of formal school education and/or 72 or more years
of age, and MMSE score <23 otherwise (follows the MMSE
validation study for the Portuguese population; Guerreiro et al.,
1994). All participants were community dwellers. For final
analysis purposes, subjects with prior history of renal failure,
FIGURE 1 | Overview of the participant flowchart.
cerebrovascular disorders, osteomalacia, any other bone disease,
or those who were on calcium and/or vitamin D supplements
were excluded. Individuals who presented estimated glomerular
filtration rate below 50 ml/min/1.73m2 and/or who did not
have 25(OH)D serum concentration data available were also
excluded. The final sample for consideration to the longitudinal
analysis was of 64 participants, all of them attended the complete
evaluation sessions and had a ‘‘seasonal-adjusted’’ vitamin D
evaluation (Figure 1).
The study was conducted in accordance with the Declaration
of Helsinki and approved by national and local ethics review
boards. All study goals and nature of the tests were explained to
the potential participants and informed signed consent obtained.
Analytical Methods
The season of blood collection was dichotomized into Winter-
Spring (between 21st December and 20th June) and Summer-
Autumn (between 21st June and 20th December), based on the
usual solar solstices/equinoxes’ dates. All subjects underwent
fasting for morning blood collection. Blood samples were
collected, centrifuged and stored at −20◦C until 25(OH)D
levels determination. A seasonal-adjusted mean 25(OH)D levels
were obtained for each participant with two blood samples
performed on a different season collection (Winter-Spring and
Summer-Autumn) over a 1–2 years period follow-up to create
an individual ‘‘season-adjusted’’ value (n = 64). The 25(OH)D
measurement was obtained by a high-performance liquid
chromatography-tandem mass spectrometry (LC-MS/MS)
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method (Waters Corporation, Milford, MA, USA) with a
coefficient of variation of 4.9%. As expected (since individuals
under supplementation were excluded from the study),
25(OH)D2 levels were negligible (corresponded to less than
1% of the full D2+D3 concentration). Therefore, total 25(OH)D
levels reported here correspond to the 25(OH)D3 determination.
Vitamin D deficiency definition based on serum 25(OH)D
values is not consensual. For description purposes, we
categorized into three groups based on: 30 nmol/l (12 ng/ml),
50 nmol/l (20 ng/ml) and 75 nmol/l (30 ng/ml) 25(OH)D
cut-point levels (‘‘deficiency,’’ ‘‘adequacy’’ and ‘‘optimal’’
thresholds, respectively; Holick et al., 2011).
Vitamin D Intake
Vitamin D intake was assessed by a 24 h diet recall questionnaire.
This estimation was performed using the Nutrilogr software
(Nutrilog SAS, France), resorting to the release 23 of the United
States Department of Agriculture National Nutrient Database for
Standard Reference and adapted to the Portuguese foods using
the Portuguese Food Composition Database (INRJ, 2018). Food
vitamin D fortification is not commonly practiced in Portugal
(Barroso, 2014).
Cognitive Assessment
A team of trained psychologists performed the
cognitive/neuropsychological assessments. A test battery
was used for socio-demographic characterization and to evaluate
multiple neuropsychological dimensions, including cognition
profiles [general cognitive status and executive (EXEC) and
memory (MEM) functions], as previously reported (Costa
et al., 2013). Briefly, these included: Graffar socio-demographic
scale, digit-span forward and backward test, Stroop color and
word test, controlled oral word association test (COWAT),
selective reminding test (SRT), digit symbol substitution test
(DSST) and MMSE (scores adjusted for cognitive impairment
and Portuguese population; Guerreiro et al., 1994). A Principal
Component Analysis was performed in order to allocate the
multiple test variables into composite components/dimensions,
as previously reported (Santos et al., 2013). Summarily, this
resulted in the identification of significant dimensions: memory
(MEM; SRT test variables: consistent long-term retrieval,
long-term storage and delayed recall) and general/executive
function (EXEC; COWAT letters F-A-S admissible parameter;
Stroop parameters: words, colors and words/colors, digits
parameters: forward and backward; MMSE). A z-score for
the cognitive composite was calculated and used to select
normal extreme values and select ‘‘Poor’’ and ‘‘Good’’ cognitive
performers. In our population, the suitability of using this battery
of cognitive tests to measure two latent constructs, memory
and executive functioning, was previously demonstrated
by a longitudinal invariance analysis across the follow-up
(Moreira et al., 2018).
Statistical Analysis
All data are presented as the mean (median), standard deviation
(SD); inter-quartile-range (IQR) for normally (non-normally)
distributed data. All continuous variables were checked for
normality using the Shapiro-Wilk normality test. Unpaired t-test
and Mann-Whitney U-test were used to compare continuous
variables between the two groups, as appropriate. Wilcoxon
matched-pairs signed-rank test was performed to compare paired
variables that failed normality tests. Fisher’s exact test was used
for categorical variables. The confidence interval of a proportion
was obtained by the modified Wald method. Univariate analysis
with Spearman’s rank correlation was performed to assess linear
relationship between 25(OH)D levels and the different cognitive
domain scores (MEM and EXEC) and its temporal trends,
stratified by cognitive group. Amultiple linear regression analysis
was conducted to explore the association between seasonal-
adjusted 25(OH)D levels and age, gender and vitamin D intake
estimation. Similarly, a multiple linear regression analysis was
done to evaluate the prediction of Memory/Executive function
scores over time by seasonal-adjusted 25(OH)D levels, adjusted
to age, gender, baseline cognitive group and education level.
Effect size estimates were calculated with Cohen’s d and η2
for continuous variables with parametric and non-parametric
comparisons, respectively; r for Wilcoxon matched paired test;
φ coefficient for Fisher’s exact test; and R2 and adjusted R2 for
regression analysis.
All analyses were tested at the 0.05 level of significance and
performed using IBM SPSS Statistics, v.21 (IBM, New York,
NY, USA) and GraphPad Prism, v.6.00 (GraphPad Software, La
Jolla, CA, USA). Effect size estimates were evaluated by Cohen’s
published benchmark classes (small, medium and large) with the
following proposed cut-points: 0.2, 0.5 and 0.8 for Cohen’s d;
0.01, 0.06, 0.14 for η2; 0.1, 0.3 and 0.5 for r and φ coefficient;
and 0.02, 0.13, 0.26 for R2 (Cohen, 1988).
RESULTS
After exclusion criteria, the final sample included 64 individuals
with a mean age of 65 years (SD 8 years), a women ratio
of 0.47 (n = 30) and a median follow-up of 18 months
(min–max: 16–22 months). Median 25(OH)D levels were higher
during Summer-Fall when compared to Winter-Spring season
(55 nmol/l vs. 43 nmol/l, p = 0.01, η2 = 0.06). The overall median
seasonal-adjusted serum 25(OH)D level was 47 nmol/l (IQR
38–60 nmol/l; range 13–114 nmol/l). Total study population
characteristics are presented in Table 1. Overall vitamin D
deficiency (below 30 nmol/l) was found in 10 subjects (16%,
95% CI 9–27%), with only seven participants (11%, 95% CI
5–21%) surpassing the threshold of optimal 25(OH)D serum
concentration (≥75 nmol/L). Thirty-eight participants (59%,
95% CI 47–71%) had 25(OH)D levels below 50 nmol/l. These
proportions were not different between ‘‘Good’’ and ‘‘Poor’’
groups (Table 1). The estimated median vitamin D intake was
0.9 µg (36 IU) per day [IQR 0.2–3.1 µg (8–124 IU) per day],
and not different among cognitive groups (1.5 vs. 0.5 µg/day,
p = 0.06), with a moderate/low practical effect size (η2 = 0.06).
On univariate analysis, ‘‘Good’’ performers had higher
education (p = 0.004, φ = 0.37) when compared to ‘‘Poor’’
performers. Cognitive domain scores at baseline and final
evaluation were different between the two groups (p < 0.001),
with a high practical effect size (η2 = 0.72), for both domains.
MEM score tends to decrease over time in both groups
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TABLE 1 | Study population characteristics by cognitive performance group, n = 64.
Total (n = 64) “Poor” (n = 27) “Good” (n = 37) p Effect size
Socio-demographic features
Sex
Female, n (%) 30 (47) 14 (52) 16 (43) 0.61 0.09
Age, mean (SD), years 65 (8) 67 (7) 64 (9) 0.09 0.04
Education level above 4-years, n (%) 17 (27) 2 (8) 15 (41) 0.004 0.37
Vitamin D parameters
Seasonal-adjusted median serum 25(OH)D
concentration, nmol/l (IQR)
47 (38–60) 47 (40–54) 47 (36–61) 0.82 0.001
Vitamin D status [serum 25(OH)D levels]
Below 30 nmol/l (“deficient”), n (%) 10 (16) 3 (11) 7 (19) 0.50 0.11
Below 50 nmol/l (“inadequate”), n (%) 38 (59) 16 (59) 22 (60) >0.99 0.002
Between 50 and 74 nmol/l (“adequate”), n (%) 19 (30) 9 (33) 10 (27) 0.60 0.07
75 nmol/l or above (“optimal”), n (%) 7 (11) 2 (7) 5 (14) 0.69 0.01
Vitamin D intake estimation, µg/day, median (IQR)∗ 0.9 (0.2–3.1) 0.5 (0.1–2.3) 1.5 (0.2–5.6) 0.06 0.06
Cognitive scores and trends, Median (IQR)
Baseline MEM score 0.23 (−0.97 to 0.74) −0.98 (−1.27 to −0.73) 0.62 (0.35–0.98) <0.001 0.72
Baseline EXEC score 0.09 (−0.84 to 0.81) −0.89 (−1.05 to −0.72) 0.70 (0.41–1.27) <0.001 0.72
Last MEM score −0.65 (−1.19 to 0.49) −1.16 (−1.49 to −0.91) 0.09 (−0.65 to 1.04) <0.001 0.35
Last EXEC score −0.17 (−0.94 to 0.89) −0.96 (−1.26 to −0.55) 0.793 (0.45–1.31) <0.001 0.71
MEM score Trend −0.30 (−0.71 to 0.13) −0.19 (−0.45 to 0.19) −0.44 (−1.23 to 0.11) 0.03 0.04
EXEC score Trend −0.004 (−0.11 to 0.14) −0.003 (−0.12 to 0.16) −0.009 (−0.10 to 0.14) 0.69 0.003
IQR, interquartile range; MEM, memory dimension composite; EXEC, executive function dimension composite. ∗n = 63, 27 vs. 36.
TABLE 2 | Spearman’s rank correlation (rs) between 25(OH)D levels and MEM and EXEC scores and its temporal trends (in both “Poor” and “Good” performers).
“Poor” (n = 27) “Good” (n = 37)
Baseline 25 (OH)D Seasonal-adjusted 25 (OH)D Baseline 25 (OH)D Seasonal-adjusted 25 (OH)D
Baseline MEM score −0.25 −0.06 0.31 0.25
Baseline EXEC score −0.52a −0.05 0.22 0.16
Last MEM score −0.21 −0.05 0.20 0.16
Last EXEC score −0.26 −0.01 0.11 0.08
MEM score trend 0.15 0.12 0.10 0.08
EXEC score trend 0.24 0.27 −0.13 −0.03
ap = 0.006.
but reached statistical significance only in the ‘‘Good’’ group
(p< 0.001), with a very high practical effect size (r = 0.56). EXEC
scores were stable (‘‘Poor’’: p = 0.83, r = 0.04; ‘‘Good’’: p = 0.53,
r = 0.10) and not different between ‘‘Poor’’ and ‘‘Good’’ groups
(p = 0.69, η2 = 0.003), with low practical effect size. There was
no association between baseline 25(OH)D levels and MEM and
EXEC scores (at baseline, last and longitudinal variation) in both
groups, except for the first EXEC score obtained in the ‘‘Poor’’
performance group, with a high negative correlation score
(rs = −0.52, p = 0.006; Table 2). Seasonal-adjusted 25(OH)D
levels were not correlated to any MEM and EXEC scores or to
its longitudinal variation in both groups (Table 2).
To explore the association between the observed variations
in MEM and EXEC scores over time with seasonal-adjusted
25(OH)D levels adjusted for baseline age, gender, cognitive
performance and education level, a multiple linear regression
analysis was performed (Table 3). In this fully adjusted
model, 25(OH)D seasonal-adjusted serum concentration failed
to predict cognitive performance over time (MEM score trend,
p = 0.96, with moderate effect size: R2 = 0.19, adjusted R2 = 0.12;
EXEC score trend, p = 0.47, with low effect size: R2 = 0.07,
adjusted R2 = −0.005). Being a ‘‘Poor’’ performance individual
was linked to a less detrimental decay in MEM score over time
(β = 0.68, 95% CI 0.29–1.08, p = 0.001). No other variable
evaluated showed a relevant effect on MEM or EXEC score
trends (Table 3).
DISCUSSION
In this longitudinal study with a healthy non-demented older
cohort, we found no association between standardized season-
adjusted 25(OH)D levels and the variation of the ‘‘memory’’
and ‘‘executive’’ cognitive domains over a median follow-up
of 18 months.
An important seasonal effect over cognitive performance is
currently recognized, with annual variations in brain function
reaching a peak in late Summer and early Fall and declining
in late Winter and early Spring (Meyer et al., 2016; Lim et al.,
2018). This observation may help explain some intraindividual
cognitive changes that develop at specific times of the year and
the importance of seasonal adjusting when exploring cognitive
associations with other variables that share circannual cycles.
We observed a negative correlation between baseline 25(OH)D
values and baseline EXEC score in the ‘‘Poor’’ performers
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TABLE 3 | Association between observed Memory/Executive Function scores trend with age, gender, cognitive group, education level and “seasonal-adjusted”
25(OH)D levels predicted by multiple linear regression analysis (n = 64; MEM score trend, p = 0.96, R2 = 0.19, adjusted R2 = 0.12; EXEC score trend, p = 0.47,
R2 = 0.07, adjusted R2 = −0.005).
MEM score trend EXEC score trend
β (95% CI) p β (95% CI) p
Age (years) −0.01 (−1.95 to 1.82) 0.29 −0.002 (−0.01 to 0.006) 0.60
Gender (Exposure: Male) −0.04 (−0.43 to 0.35) 0.84 −0.07 (−0.12 to 0.05) 0.25
Cognitive performance (Exposure: “Poor”) 0.68 (0.29–1.08) 0.001 −0.01 (−0.14 to 0.11) 0.84
Education Level (years) 0.05 (−0.004 to 0.11) 0.07 0.01 (−0.005 to 0.03) 0.15
Seasonal-adjusted 25(OH)D levels (nmol/l) 0.001 (−0.01 to 0.01) 0.96 −0.001 (−0.004 to 0.002) 0.47
group, but this effect was lost after adjusting 25(OH)D for
season. Our observations are in accordance with the few
studies that evaluated cognitive performance and behavior
in populations exclusively with vitamin D insufficiency like
ours. Some authors using a very low 25(OH)D cut-point level
(25 nmol/l), have shown a small or no clear positive association
with cognitive performance (Aung et al., 2006; Annweiler
et al., 2010). Others, using a somewhat higher 25(OH)D
threshold levels, have reported better cognitive performance
associated with these ‘‘healthier’’ vitamin D levels (Llewellyn
et al., 2011; Annweiler and Beauchet, 2014). Recently, a similar
study with non-demented German older adults also found
that the lowest 25(OH)D quintiles were associated with higher
cognitive decline (based on a Cognitive Telephone screening
instrument score—COGTEL) over an average 5-year follow-up
time (Perna et al., 2014). Interestingly, one study reported
that this ‘‘positive’’ effect of 25(OH)D concentrations and
cognition tests were only present in the sub-group with low
number of years of formal education (Assmann et al., 2015).
In the current study, despite the overall low level of standard
school education years, no such relationship was observed.
Further studies are required to clarify whether there is a
minimal 25(OH)D threshold that provides neuroprotection in
still cognitive healthy populations.
Our multivariate analysis reveals no effect of 25(OH)D on the
temporal trends observed in the MEM and EXEC composites
in both groups. With this regard, it is important to consider
that in contrast to most studies reporting association with single
neuropsychological tests, here multiple cognitive components
were characterized and grouped into a comprehensive
neuropsychological domain composite. When considered alone,
the various studies performed to date were seldom concordant.
Two recent meta-analyses, including 14 longitudinal studies,
indicate that lower 25(OH)D levels are indeed associated with
some executive dysfunctions (especially on mental shifting,
information updating and processing speed) and cognitive
decline. However, they do not provide clear evidence for the
relation of 25(OH)D levels with episodic memory or whether
there is a 25(OH)D threshold/optimal therapeutic window
for supplementation to prevent cognitive decline later in life
(Annweiler et al., 2013; Goodwill and Szoeke, 2017). These
same inconsistencies have been reported more recently in
larger and longer prospective cohorts. In a large study spanning
over 20-years, 25(OH)D levels measured in midlife were
not associated with more rapid cognitive decline over the
follow-up period (Schneider et al., 2018). However, another
large US-based cohort submitted to extensive neuro-cognitive
tests covering several domains found that after a mean 5-year
follow-up, higher baseline serum 25(OH)D concentrations were
linked to a slower rate of decline in a test of verbal fluency
(Beydoun et al., 2018). Moreover, a very recent study failed
to observe any relationship between baseline 25(OH)D levels
and cognition or cognitive decline over 2 years of follow-up
by evaluating 1499 Puerto Rican participants living in the
Boston Area (aged 45–75 years old at baseline) and using
a principal-components analysis to quantify the association
between 25(OH)D and the longitudinal performance of two
major cognitive features: executive function, and memory
(Palacios et al., 2019).
Unfortunately, current published intervention trials
addressing vitamin D and cognition have not provided a
conclusive answer (Dhesi et al., 2004; Przybelski et al., 2008;
Dean et al., 2011; Stein et al., 2011; Rossom et al., 2012; Pettersen,
2017; Rutjes et al., 2018; SanMartin et al., 2018; Castle et al.,
2019). A recent small intervention trial showed general cognitive
status improvement in 16 mild cognitive impaired patients after
18 months of vitamin D supplementation (but not in healthy
controls or those already diagnosed with dementia; SanMartin
et al., 2018). Improved visual memory was observed in healthy
Canadian adults with ‘‘insufficient’’ baseline 25(OH)D levels
(below 75 nmol/l) that were supplemented with high doses of
vitamin D (4,000 IU per day) for 18 weeks, without replication
in other cognitive domains (Pettersen, 2017). More recently,
in a randomized controlled trial with 69 overweight/obese
postmenopausal women with 25(OH)D levels less than 75 nmol/l
and divided in three different intervention doses of vitamin D
(600, 2,000 or 4,000 IU per day), only the intermediate group
performed better in learning and memory tests after 1 year
supplementation (Castle et al., 2019). These results reflect
the complexity behind any potential vitamin D effect on
cognition and the need for better-designed studies, probably
including distinct vitamin D insufficiency status populations,
supplement doses, exposures periods, age groups and baseline
cognitive performances.
Another important observation of our study pertains with the
25(OH)D status of the individuals in the study population. Levels
below 30 nmol/l were found in 16% and below 50 nmol/l in
almost 60%. These results provide a less dramatic indication of
vitaminD deficiency/inadequacy compared to recently published
data on the Portuguese population (levels below 30/50 nmol/l
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were detected in 40/69% of a nationwide cluster sample of
1,500 Portuguese subjects over 65 years old or 38/86% of
a subsample of another national cross-sectional study that
included Portuguese adults registered in mainland primary
health care centers; Raposo et al., 2017; Santos et al., 2017). Much
of the differences reported in 25(OH)D levels are probably based
on the season-geography confounder and on methodological
procedures used (Cashman et al., 2016). In the present study, the
LC-MS/MS was used, which provides a more accurate measure
of vitamin D status when comparing to some immunological
methods used in routine determinations, and this technicality
is likely to justify the main differences found between this
and other studies coming from similar Portuguese populations
(Wallace et al., 2010).
Self-reported daily intake of vitamin D data deserves
consideration. Despite the limitation of self-reported data, the
estimated median vitamin D intake was only of 0.9 µg/day
(36 IU/day; IQR 0.2–3.1 µg/day, 8–124 IU/day), with all
subjects evaluated failing to achieve the recommended vitamin
D intake (15 µg/day for adults with less than 70 years and
20 µg/day for those older than 70 years; Aloia, 2011). Main
dietary sources of vitamin D are meat, fish, milk and cheese.
Overall, in our cohort, meat consumption (meat/fish or eggs
was present in 54% of the meals with no individuals reporting
being vegetarian—data not shown) was relatively small (mean
of 145 mg per meal—data not shown). The current Portuguese
Food Composition Database states that eggs and meat have
generally low levels of vitamin D (between 0.7–1.7 µg per
100 mg; INRJ, 2018). Vitamin D supplementation in food is
not mandatory in Portugal and most ‘‘supplemented’’ dairy
products present levels of vitamin D between 0.3 and 1.5 µg
per 100 ml or 100 g (Parreira et al., 2015). These two facts may
imply that, in our sample, even an ‘‘usual’’ daily consumption
of 200 g of meat/eggs or ‘‘supplemented’’ dairy products, would
represent no more than 20% of the recommended intake of
vitamin D. Current habitual intakes of vitamin D in most
other countries are also low (typically around 1–4 µg/day),
meaning that the proposed reference intake value has to be
covered mostly by additional vitamin D supplements and/or
endogenous synthesis (Brown et al., 2013). This observation
suggests that circulating vitamin D levels in these individuals
is most likely provided by exposure to sun. It is important to
recall that the present study focuses on a population of active
healthy individuals living in the community and that despite
the tendency observed towards higher vitamin D intake in the
‘‘Good’’ performing group, no such reflectionwas present in their
circulating 25(OH)D levels.
The study main strengths are grounded on the exhaustive
cognitive evaluation performed longitudinally with the
construction of coherent executive and memory cognitive
domain composites and a two-point season-opposite 25(OH)D
levels determination. However, some important limitations of
the study should be considered. First, there was a relatively
small number of participants available for final exploration
with a complete longitudinal cognitive assessment, which
decreased the sensitivity to detect any small effect and prevented
further analysis comparing distinct groups based on more
extreme 25(OH)D distribution. Second, there was a relatively
short time between the two cognitive evaluations (min-max:
16–22 months), which may have also impaired the ability to
detect subtle intra or inter-individual cognitive time-dependent
differences, underestimating potential associations with
25(OH)D levels. Third, despite the two seasonal opposite
25(OH)D determinations separated by at least 1.5-years, no
‘‘real’’ prolonged longitudinal evaluation of 25(OH)D levels was
made. This means that individual vitamin D status appraisal
may have resulted in a rather 2-year ‘‘cross-sectional’’ estimation
and prevented, therefore, any assessment of its expanded
longitudinal effect on cognition. Also relevant is the fact that
the study population was almost homogenously vitamin D
insufficient. This feature, frequently found in other studies with
older adults, makes it harder to discover any associations given
the lack of 25(OH)D levels inter-individual variability found in
these cohorts (Annweiler et al., 2011).
In summary, in this Portuguese older healthy population,
serum 25(OH)D levels were not associated with cognitive
domain composite scores for an average 18 months follow-up,
in both stronger and poorer cognitive performers. Despite the
lack of agreement about what should be the optimal circulating
25(OH)D levels, the conclusions of the present study are limited
to the neurocognitive outcomes obtained in older individuals
with relatively stable low 25(OH)D levels and during a short
longitudinal period. Further studies should address the role of
vitamin D during several brain development time frames and its
role in cognitive aging.
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